Lifecycle Leader for Giredestrant

Genentech • Daly City, CA

1d • Hybrid

About The Position

As a Lifecycle Leader for Giredestrant, you will lead the asset(s) strategy and portfolio from research through to the patient. You will play a critical role in leading the Life Cycle Team (LCT) and acting as accountable to the Late Stage Portfolio Committee (LSPC), maximizing the value of a product for patients, society, and the company by leading an integrated, global and cross-functional strategy and team.

Requirements

• A bachelor's degree is required, preferably in a marketing, business management, or life sciences discipline.
• Demonstrable previous accomplishments should include developing and overseeing the execution of breakthrough development and/or commercial strategies that led to considerable financial results.
• Product management and launch experience.
• An ability to quickly come up to speed and navigate technical, supply, development and regulatory challenges utilising a deep understanding of global health systems, access and reimbursement challenges.
• Therapeutic Area (oncology) and breast cancer knowledge and experience is mandatory.
• Outstanding leadership skills with a proven track record in building teams and the ability to influence in a cross-functional environment.
• Exceptional strategic orientation and agility, with an outstanding ability to develop a long-term vision and a deep understanding of the global pharmaceutical/biotechnology industry to create robust and innovative business strategies.
• Exceptional stakeholder management across levels, prioritization of work packages, providing teams clarity and leading through an evolving environment are key skills that are mandatory.

Nice To Haves

• MD, PhD, or other relevant graduate, postgraduate degree, or MBA (depending on the Lifecycle of the product) is an additional plus.

Responsibilities

• Partner with the Commercial Leadership Team, Pharma Development and others to unlock the value of Giredestrant through up-coming launches as well as through on-going and future clinical studies.
• Serve as the key point of accountability in execute on the short-term and shape the long-term vision and strategy for Giredestrant - which can be large and/or complex - in partnership with various internal functions ranging from research, development, key markets, commercial, etc. and external partners.
• Support relevant early development asset teams, licensing, and other business development activities to grow the portfolio.
• Driving alignment and integrated decision-making with the various cross-functional teams to realise the potential of the asset(s), within the context of the disease area and therapeutic area strategies.
• Working with other asset and lifecycle teams to realise portfolio opportunities.
• Serving as an inspiring leader, aligning people towards a vision while building a culture of accountability, collaboration, inclusion, and trust.
• Serving as a thought partner and sounding board for cross organisation teams and relevant internal and external stakeholders, ensuring that franchise and enterprise goals are met.
• Accountable for the strategic fit, resource ask and the delivery of the business case to the governance.
• Continually assess and evolve the asset strategy in the context of external dynamics and new opportunities, by evaluating and triggering different value levers to maximise the asset's potential.
• Integrated leadership to propose and deliver indications, formulations, devices, diagnostics and digital tools, along with the evidence generation strategy, to address the appropriate treatable population in collaboration with various internal teams and research organisations.

Benefits

• Relocation assistance is available for this position.
• A discretionary annual bonus may be available based on individual and Company performance.
• This position also qualifies for the benefits detailed at the link provided below.

What This Job Offers

• Job Type: Full-time
• Career Level: Senior
• Number of Employees: 5,001-10,000 employees